DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+34.45%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$3.43B
AUM Growth
+$3.43B
(+9%)
Cap. Flow
-$415M
Cap. Flow
% of AUM
-12.09%
Top 10 Holdings %
Top 10 Hldgs %
38.81%
Holding
112
New
25
Increased
11
Reduced
35
Closed
19
Top Buys
| 1 |
Hologic
HOLX
|
$78.1M |
| 2 |
Larimar Therapeutics
LRMR
|
$66.1M |
| 3 |
VIVO
Meridian Bioscience Inc
VIVO
|
$38.7M |
| 4 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$34.6M |
| 5 |
Generation Bio
GBIO
|
$24.9M |
Top Sells
| 1 |
AdaptHealth
AHCO
|
$255M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$219M |
| 3 |
Q32 Bio
QTTB
|
$62.7M |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
$54.8M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
$54.6M |
Sector Composition
| 1 | Healthcare | 65.56% |
| 2 | Financials | 0.55% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Protagonist Therapeutics
PTGX
$3.62B
| $17.9M | 0.52% |
+1,013,495
| New | +$17.9M |
|
52
Ardelyx
ARDX
$1.57B
| $17.7M | 0.52% |
2,561,554
-521,446
| -17% | -$3.61M |
|
53
Adverum Biotechnologies
ADVM
$68.2M
| $17.4M | 0.51% |
833,895
-1,241,105
| -60% | -$25.9M |
|
54
Natera
NTRA
$23B
| $16.2M | 0.47% |
324,038
-991,962
| -75% | -$49.5M |
|
|
SIEN
55
DELISTED
Sientra, Inc.
SIEN
| $16.1M | 0.47% |
4,162,804
-64,876
| -2% | -$251K |
|
|
LUMO
56
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $15.4M | 0.45% |
936,169
| – | – |
|
57
Cerus
CERS
$251M
| $14.6M | 0.42% |
2,204,700
| – | – |
|
58
Protara Therapeutics
TARA
$125M
| $12.7M | 0.37% |
432,670
| – | – |
|
|
TPTX
59
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $12.2M | 0.35% |
188,490
-224,831
| -54% | -$14.5M |
|
60
Enliven Therapeutics
ELVN
$1.24B
| $11.7M | 0.34% |
424,000
-76,000
| -15% | -$2.1M |
|
61
Owens & Minor
OMI
$423M
| $11.3M | 0.33% |
+1,477,000
| New | +$11.3M |
|
62
Keros Therapeutics
KROS
$640M
| $11.3M | 0.33% |
+300,000
| New | +$11.3M |
|
|
OXFD
63
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $11M | 0.32% |
845,000
+690,604
| +447% | +$8.98M |
|
64
Oric Pharmaceuticals
ORIC
$1.03B
| $10.1M | 0.29% |
+300,000
| New | +$10.1M |
|
65
Applied Therapeutics
APLT
$73.7M
| $10.1M | 0.29% |
278,359
| – | – |
|
|
ITMR
66
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
| $9.28M | 0.27% |
499,136
| – | – |
|
67
Xeris Biopharma Holdings
XERS
$1.27B
| $8.46M | 0.25% |
3,178,551
-254,740
| -7% | -$678K |
|
68
Select Medical
SEM
$1.6B
| $8.32M | 0.24% |
565,000
-498,000
| -47% | -$7.34M |
|
69
Spyre Therapeutics
SYRE
$1.02B
| $7.63M | 0.22% |
+825,000
| New | +$7.63M |
|
|
AERI
70
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $7.3M | 0.21% |
494,216
-2,037,931
| -80% | -$30.1M |
|
|
AKUS
71
DELISTED
Akouos, Inc. Common Stock
AKUS
| $7.16M | 0.21% |
+318,034
| New | +$7.16M |
|
|
ARYBU
72
DELISTED
ARYA Sciences Acquisition Corp II Unit
ARYBU
| $5.8M | 0.17% |
+500,000
| New | +$5.8M |
|
|
MNK
73
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $5.28M | 0.15% |
1,970,687
-2,056,063
| -51% | -$5.51M |
|
74
Cabaletta Bio
CABA
$144M
| $5.17M | 0.15% |
464,252
-820,061
| -64% | -$9.14M |
|
75
Neuronetics
STIM
$216M
| $3.27M | 0.1% |
1,693,317
+118,317
| +8% | +$228K |
|